期刊文献+

2004~2010年武汉同济医院临床分离多重耐药菌株监测分析 被引量:9

The surveillance of multi-drug resistance of Tongji hospital during 2004 to 2010
原文传递
导出
摘要 目的了解武汉同济医院2004年至2010年临床分离多重耐药菌株的检出情况。方法对临床分离菌株,采用纸片扩散法按统一的方案进行药敏试验。按照CLSI 2009年标准进行判断。结果 2004年至2010年该院耐甲氧西林金葡菌(MRSA)和耐甲氧西林凝固酶阴性葡萄球菌(MRSCN)的检出率分别在35.6%~63.8%和21.5%~61.4%。2004年至2010年共检出36株耐万古霉素肠球菌(VRE)。大肠埃希菌产ESBLs株检出率在29.6%~81.7%,肺炎克雷伯菌产ESBLs株检出率在36.0%~56.6%,产酸克雷伯产ESBLs株检出率在35.3%~67.4%,奇异变形杆菌产ESBLs株检出率在0~26.2%。自2005年起每年均有泛耐药的铜绿假单胞菌和鲍曼不动杆菌的检出。结论该院2004年至2010年多重耐药菌株呈增多趋势,尤其是VRE和泛耐药的铜绿假单胞菌和鲍曼不动杆菌的出现,给临床治疗带来了严峻挑战。 Objective To investigate the occurence of multi-drug resistance strains in Tongji Hospital during 2004 to 2010.Method The bacteria from our hospital during 2004 to 2010 were analyzed.Bacterial susceptibility testing was carried out according to an agreed protocol using Kirby-Bauer method.Resultswere analyzed according to CLSI 2009.Result Methicillin resistant strains in S.aureus(MRSA) and coagulase negative staphylococcus(MRSCN) accounted for 35.6% to 63.8% and 21.5% to 61.4% from 2004 to 2010 respectively.36 strains of Vancomycin-resistant Enterococcus(VRE) were found from 2004 to 2010.About 29.6% to 81.7% of E.coli,36% to 56.6% of K.pneumoniae,35.3% to 67.4% of K.oxytoca and 0 to 26.2% of P.mirabilis isolates were ESBLs-producing strains.The pandrug resistance of P.aeruginosa and A.baumsnnii were found every year since 2005.Conclusion The multi-drug resistance had been getting more serious during 2004 to 2010,especially the emerge of VRE and the pandrug resistance of P.aeruginosa and A.baumsnnii,which is a challenge for clinical management.
出处 《中国微生态学杂志》 CAS CSCD 2012年第2期151-153,共3页 Chinese Journal of Microecology
关键词 多重耐药 泛耐药 耐万古霉素的肠球菌 超广谱Β-内酰胺酶 Multi-drug resistance Pandrug resistance Vancomycin resistant enterococci Extended spectrum beta-lactamases
  • 相关文献

参考文献3

二级参考文献20

  • 1赵宗珉,赵金满,万建华.肺炎克雷伯杆菌肝脓肿与非肺炎克雷伯杆菌肝脓肿的临床比较[J].世界华人消化杂志,2006,14(16):1582-1586. 被引量:25
  • 2战微微,蒋天安,潘农.肺炎克雷伯杆菌肝脓肿超声诊断及介入治疗价值分析[J].浙江医学,2007,29(3):283-284. 被引量:4
  • 3Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing [S]. Fifteenth Informational Supplement, 2007, M100-S17.
  • 4Sakoulas G, Moellering RC Jr. Increasing antibiotic resistamong methicillin-resistant Staphylococcus aureus strains[J]. Clin Infect Dis,2008,46(S5) :S360-S367.
  • 5Ball JM,Walters LJ,Turnidge D, et al. hVISA are commom among vacomycin-susceptible methicillin-Staphylococcus aureus (MRSA) : report from SENTRY Asia-Pacific regio [abstract C2-1160] [C]//Program and abstracts of 46th annual meeting of the Interscience Conferenee on AntimicrobialAgents and Chemotherapy (San Francisco). Washington , DC:American Society for Microbiology,2006.
  • 6Clinical and Laboratory Standads Institute. Performance Standards for Antimicrobial Susceptibility Testing [S]. Fifteenth Informational Supplement, 2006, M100-S16.
  • 7Soriano A, Marco F, Martinnez JA,et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia [J]. Clin Infect Dis, 2008, 46(2):193-200.
  • 8Clinical and Laboratory Standads Institute. Performance Standards for Antimierobial Susceptibility Testing [S]. Fifteenth Informational Supplement, 2009, M100-S19.
  • 9Wootton M,Howe RA,Hillman R,et al. A modified population analysis profile (PAP) method to detect hetero resistance to vancomycin in Staphylococcus aureus in a UK hospital[J]. J Anitimicrob Chemother,2001,47(4) :399-403.
  • 10Appelbaum PC. Microbiology of antibiotic resistance in Stapylococcus aureus[J]. Clin Infect Dis, 2007, 45 (Suppl 3) : S165-S170.

共引文献238

同被引文献75

  • 1王辉,孙宏莉,宁永忠,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.不动杆菌属多重耐药及泛耐药的分子机制研究[J].中华医学杂志,2006,86(1):17-22. 被引量:183
  • 2马玉琴,罗莉.526株铜绿假单胞菌感染的分布与耐药性[J].华中医学杂志,2006,30(2):144-145. 被引量:5
  • 3王豫平,王慕云,廖致红.多重耐药铜绿假单胞菌感染相关因素分析[J].中华医院感染学杂志,2006,16(9):1059-1060. 被引量:59
  • 4鲁卫平,安琳.可诱导克林霉素耐药金黄色葡萄球菌医院感染分子流行病学调查[J].重庆医学,2006,35(23):2115-2117. 被引量:7
  • 5Zavascki AP,Carvalhaes CG,Picao RC,et al. Multidrug-re-sistant Pseudomonas aeruginosa and Acinetobacter bauman-nii :resistance mechanisms and implications for therapy[ J].Expert Rev Anti-Infect Ther,2010,8( 1) :71 -93.
  • 6Rafailidis PI, Ioannidou EN, Falagas ME. Ampicillin/sul-bactam :current statusin severe bacterial infections [ J ].Drugs ,2007,67(13):1 829-1 849.
  • 7Oliveira MS,Prado GVB,Costa SF,et al. An^jicillin/sulbactamcompared with polymyxins for the treatment of infectionscaused by carbapenem-resistant Acinetobacter spp[J]. Journalof Antimicrobial Chemotherapy ,2008,61 (6) :1 369 -1 375.
  • 8Warren DK, Zack JE, Mayfield JL, et al. The effect of an education pro- gram on t he incidence of cent ral venous catheter-associated bloodst ream infection in a medical ICU [J]. Chest, 2004, 126 (5) : 1612- 1618.
  • 9Peleg AY, Seifert H , Paterson DL. Acinetobacter baumannii : emergence of a successful pathogen [ J ]. Clin Microbiol Rev, 2008,21 ( 3 ) : 538- 582.
  • 10Higgins PG, Dammhayn C, Hackel M, et al. Global spread of carbapen- em-resistant Acinetobacter baumannii [ J ]. J Antimicrob Chemother, 2010,65 (2) :233-238.

引证文献9

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部